Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Blood Advances|August 30, 2023
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemiaFarhad Ravandi, Asad Bashey, James Foran, et al.
Cytotherapy|December 2, 2020
In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burdenValentina Ferrari, Alison Tarke, Hannah Fields, et al.
Leukemia|October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic LeukemiaSamer A Srour, Denái R Milton, Asad Bashey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemiaAthanasios Anagnostopoulos, Parameswaran N Hari, Waleska S Pérez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2011
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myelomaDan T Vogl, Tao Wang, Waleska S Pérez, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Blood|November 1, 2008
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantationAsad Bashey, Bridget Medina, Sue Corringham, et al.
Blood Advances|August 30, 2023
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemiaFarhad Ravandi, Asad Bashey, James Foran, et al.
Cytotherapy|December 2, 2020
In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burdenValentina Ferrari, Alison Tarke, Hannah Fields, et al.
Leukemia|October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic LeukemiaSamer A Srour, Denái R Milton, Asad Bashey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemiaAthanasios Anagnostopoulos, Parameswaran N Hari, Waleska S Pérez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2011
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myelomaDan T Vogl, Tao Wang, Waleska S Pérez, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Pageof 13